Evidence map›Paper›PMID 40295025›Full record

ArticleIn vivo (Athens, Greece)

Preoperative Anemia Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.

Kiyoko Shimada, Toru Aoyama, Itaru Hashimoto, Yukio Maezawa, Ryuki Esashi, Momoko Fukuda, Mihwa Ju, Sosuke Yamamoto, Keisuke Kazama, Natsumi Kamiya and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kiyoko Shimada *Department of Surgery, Yokohama City University, Yokohama, Japan.
Toru Aoyama *Department of Surgery, Yokohama City University, Yokohama, Japan t-aoyama@lilac.plala.or.jp.
Itaru HashimotoDepartment of Surgery, Yokohama City University, Yokohama, Japan itarum1n1@hotmail.com.
Yukio MaezawaDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Ryuki EsashiDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Momoko FukudaDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Mihwa JuDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Sosuke YamamotoDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Keisuke KazamaDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Natsumi KamiyaDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Naoko OkudaDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Ayako TamagawaDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Koji NumataDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Mamoru UchiyamaDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Aya SaitoDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Norio YukawaDepartment of Surgery, Yokohama City University, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimWe retrospectively evaluated the clinical impact of anemia during the perioperative period on both short- and long-term oncological outcomes in patients with resectable esophageal cancer who received curative treatment. PATIENTS AND

methodsWe retrospectively reviewed the medical records and collected data from consecutive patients with esophageal cancer who underwent curative resection at Yokohama City University from 2005 to 2022.

resultsA total of 198 patients were included in this study. According to previous studies and the 3- and 5- year overall survival rates, a hemoglobin level of 11 g/dl was selected as the optimal cutoff value in the present study; preoperative hemoglobin of <11 g/dl and >11 g/dl were observed in 34 patients (Hb-low group) and 164 patients (Hb-high group), respectively. The 3- and 5-year OS rates were 39.1% and 34.8%, respectively, in the Hb-low group and 70.3% and 62.1% in the Hb-high group. There were significant differences between the two groups (

conclusionPreoperative anemia is an independent prognostic factor in patients with esophageal cancer. Our results suggest its potential significance in the treatment and management of these patients.

Indexed as

AnemiaEsophageal NeoplasmsAdultAgedAged, 80 and overFemaleHemoglobinsHumansMaleMiddle AgedNeoplasm StagingPreoperative PeriodPrognosisRetrospective StudiesTreatment OutcomeHemoglobinsanemiaEsophageal cancerprognostic factorsurvival

Identifiers

PMID40295025
PMCPMC12042014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.